Clinical trial
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With…
NCT00129623 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00129623 |
|---|---|
| Title | A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia |
| Official title | Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Menopausal Osteopenia |
| Intervention type | Drug |
| Interventions | Placebo, ibandronate [Bonviva/Boniva] |
| Enrollment | 160 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 12, 2005 |
| Last update posted | Jan 11, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: